series-a
Stage
2018
Founded
1
Investors
About
GlycoEra is a Swiss biotech company developing novel biologic drugs using its proprietary GlycoExpress™ platform. This platform enables the precise and efficient production of biologics with tailored glycosylation profiles to enhance therapeutic properties for various diseases.
Explore GlycoEra's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.